A novel chelate Eu(TTA) 2(PMTBBP)Phen, which contained ligand 1 pheny 3 methyl 4 (4 t butylbenzoyl) 5 pyrazolone(HPMTBBP), 4,4,4 trifluro 1 (2 thienyl) 1,3 butandione(HTTA) and phenanthroline(Phen), was synthesized....A novel chelate Eu(TTA) 2(PMTBBP)Phen, which contained ligand 1 pheny 3 methyl 4 (4 t butylbenzoyl) 5 pyrazolone(HPMTBBP), 4,4,4 trifluro 1 (2 thienyl) 1,3 butandione(HTTA) and phenanthroline(Phen), was synthesized. Its chemical structure was elucidated by IR, UV, 1H NMR, MS, DSC and elementary analysis. The influence of acylpyrazolone on fluorescent intensity of the new chelate was studied. The results showed that Eu(TTA) 2(PMTBBP)Phen had more excellent PL properties and better film formation than that of Eu(TTA) 3Phen. [WT5HZ]展开更多
Crohn’s disease is a chronic inflammatory disease process involving different sites in the gastrointestinal tract. Occasionally, so-called metastatic disease occurs in extra-intestinal sites. Granulomatous...Crohn’s disease is a chronic inflammatory disease process involving different sites in the gastrointestinal tract. Occasionally, so-called metastatic disease occurs in extra-intestinal sites. Granulomatous inflammation may be detected in endoscopic biopsies or resected tissues. Genetic, epigenetic and environmental factors appear to play a role. Multiple susceptibility genes have been described in both familial and non-familial forms while the disease is phenotypically heterogeneous with a female predominance. The disorder occurs over a broad age spectrum, from early childhood to late adulthood. More than 80% are diagnosed before age 40 years usually with terminal ileal and colonic involvement. Pediatric-onset disease is more severe and more extensive, usually with a higher chance of upper gastrointestinal tract disease, compared to adult-onset disease. Long-term studies have shown that the disorder may evolve with time into more complex disease with stricture formation and penetrating disease complications (i.e., fistula, abscess). Although prolonged remission may occur, discrete periods of symptomatic disease may re-appear over many decades suggesting recurrence or re-activation of this inflammatory process. Eventual development of a cure will likely depend on identification of an etiologic cause and a fundamental understanding of its pathogenesis. Until now, treatment has focused on removing risk factors, particularly cigarette smoking, and improving symptoms. In clinical trials, clinical remission is largely defined as improved numerical and endoscopic indices for “mucosal healing”. “Deep remission” is a conceptual, more “extended” goal that may or may not alter the long-term natural history of the disease in selected patients, albeit at a significant risk for treatment complications, including serious and unusual opportunistic infections.展开更多
The title ternary complex Nd[(C5H8NS2)3(C12H8N2)] has been synthesized in absolute ethanol by the reaction of NdCl33.74H2O with ammonium pyrrolidinyldithiocarboxylate (APDC) and 1,10-phenanthroline (phenH2O) at air at...The title ternary complex Nd[(C5H8NS2)3(C12H8N2)] has been synthesized in absolute ethanol by the reaction of NdCl33.74H2O with ammonium pyrrolidinyldithiocarboxylate (APDC) and 1,10-phenanthroline (phenH2O) at air atmosphere without any cautions against moisture. The bonding characteristics of the complex were characterized by IR, showing that Nd3+ is bonded with sulfur atom in the APDC and coordinated with nitrogen atom in the phen. TG-DTG investigation indicates that the title complex was decomposed into Nd2S3 and deposited carbon in one step where Nd2S3 predominated in the final products. The enthalpy change of formation of the reaction on the title com-plex in liquid-phase has been determined by a microcalorimeter. Thermodynamic parameters (the activation en-thalpy, the activation entropy and the activation free energy) and kinetics parameters (the rate constant, the apparent activation energy, the pre-exponential constant and the reaction order) of the title reaction have been calculated. The enthalpy change of the solid-phase reaction has been obtained by a thermochemistry cycle.展开更多
A supramolecular framework, 1.5Zn（phen）3·L·3NO3 （C63H48Zn1.5N16O9S）, has been synthesized. The ligand L was synthesized by the condensation of p-aminoacetophenone with thiosemicarbazide. The crystal belo...A supramolecular framework, 1.5Zn（phen）3·L·3NO3 （C63H48Zn1.5N16O9S）, has been synthesized. The ligand L was synthesized by the condensation of p-aminoacetophenone with thiosemicarbazide. The crystal belongs to the monoclinic system, space group C2/c, with a = 31.005（2）, b = 15.114（2）, c = 24.887（3） A, β = 94.260（2）° Z = 8, V = 11630（2）A^3 Dc = 1.489 g/cm^3, Mr = 1303.29,λ（MoKa） = 0.71069 A,μ= 0.735 mm^-1, F（000） = 5368, Rint = 0.0699, R= 0.0505 and wR= 0.0707. Two independent Zn atoms are both coordinated by six N atoms from three phen ligands. π-π and C-H…π interactions among the L ligands and Zn（phen）3 cations, π-π and C-H...π interactions among the Zn（phen）3 cations and N-H...O hydrogen bonds among the L ligands and nitrate anions connect the whole structure into a 3-D supramolecular framework.展开更多
A novel Co(phen)2/C catalyst was prepared by coating cobalt(II) phenanthroline (phen) chelate on BP2000 carbon black and then heat treating in an inert atmosphere. The obtained Co(phen)2/C product with 1.0 wt% cobalt ...A novel Co(phen)2/C catalyst was prepared by coating cobalt(II) phenanthroline (phen) chelate on BP2000 carbon black and then heat treating in an inert atmosphere. The obtained Co(phen)2/C product with 1.0 wt% cobalt loading exhibits similar morphology and porosity characteristics to those of the bare BP2000. X-ray diffraction measurements demonstrate a face-centered cubic (fcc) α-Co phase embedded in the carbon support after pyrolysis. Charge/discharge tests of the lithium-oxygen cells using the prepared Co(phen)2/C catalyst show high discharge capacities of 4870 mAh g-1 (0.05 mA cm-2 ), 3353 mAh g-1 (0.1 mA cm-2 ) and 3220 mAh g 1 (0.15 mA cm-2 ), respectively. The Co(phen) 2 /C cathode exhibits reasonable reversibility with capacity retention of 1401 mAh g-1 ( 0.1 mA cm-2 ) after 10 cycles. The superior electrochemical performance of the prepared Co(phen)2/C catalyst and low cost of the phenanthroline chelating agent indicate that Co(phen)2/C is a promising cheap catalyst for lithium-air batteries.展开更多
A new compound（ClO4）2（H2O）0.5（azpy）was synthesized.Its structure was determined by single X-ray diffraction.The crystal belongs to triclinic system,space group P1.The crystallographic data:a=11.813（2）,b=12.574...A new compound（ClO4）2（H2O）0.5（azpy）was synthesized.Its structure was determined by single X-ray diffraction.The crystal belongs to triclinic system,space group P1.The crystallographic data:a=11.813（2）,b=12.574（2）,c=14.580（3）*!,a=84.048（6）,β=77.878（15）,γ=67.902（12）°,V=1961.1（7）*!3,Z=2,F（000）=926,Mr=904.57,Dc=1.532Mg/m3,μ=0.542mm-1,R1=0.0770,and wR2=0.1373.In the ctystal Mn（Ⅱ）ion is coordinated with six nitrogen from three phen ligands to form a distorted octahedron geometry.展开更多
The crystal structures of two potential tumor imaging agents and therapeutic agents -copper(Ⅱ) complexes with salicylidene-tyrosinato Schiff base and nitrogen-donor chelating Lewis base, [Cu(sal-tyr)(bipy)] 1 and [Cu...The crystal structures of two potential tumor imaging agents and therapeutic agents -copper(Ⅱ) complexes with salicylidene-tyrosinato Schiff base and nitrogen-donor chelating Lewis base, [Cu(sal-tyr)(bipy)] 1 and [Cu(sal-tyr)(phen)]2CH3OH 2 are presented. Our work is helpful to get deep understanding of novel 64Cu tumor imaging agents and therapeutic agents.展开更多
A novel β-diketone, 1-（3,4,5-trisbenzyloxy）benzoyl-5-benzoyl acetylacetone （TBAA）, and its corresponding binary Tb（Ⅲ） complex Tb（TBAA）3·2H2O and ternary complex Tb（TBAA）3Phen with 1,10-phenanthroline ...A novel β-diketone, 1-（3,4,5-trisbenzyloxy）benzoyl-5-benzoyl acetylacetone （TBAA）, and its corresponding binary Tb（Ⅲ） complex Tb（TBAA）3·2H2O and ternary complex Tb（TBAA）3Phen with 1,10-phenanthroline （Phen） were prepared. The ligand was characterized based on elemental analysis, FT-IR, and 1H NMR. The complexes were characterized with elemental analysis, FT-IR and thermogravimetry and derivative thermogravimetry （TG-DTG）. Photoluminescence measurements indicated that the energy absorbed by the organic ligand was efficiently transferred to the central Tb3＋ ions, and the complex showed intense and characteristic emissions due to the 5D4→7FJ transitions of the central Tb3＋ ions. Both complexes showed longer fluorescence lifetimes. After the introduction of the second ligand Phen group, the relative emission intensities and fluorescence lifetimes of the ternary complex Tb（TBAA）3Phen enhanced more obviously than that of the binary complex Tb（TBAA）3·2H2O. This indicated that the presence of the ligand TBAA and the second ligand Phen could sensitize fluorescence intensities of Tb（Ⅲ） ions, and the introduction of Phen group resulted in the enhancement of the fluorescence properties of the Tb（Ⅲ） ternary rare earth complex.展开更多
文摘A novel chelate Eu(TTA) 2(PMTBBP)Phen, which contained ligand 1 pheny 3 methyl 4 (4 t butylbenzoyl) 5 pyrazolone(HPMTBBP), 4,4,4 trifluro 1 (2 thienyl) 1,3 butandione(HTTA) and phenanthroline(Phen), was synthesized. Its chemical structure was elucidated by IR, UV, 1H NMR, MS, DSC and elementary analysis. The influence of acylpyrazolone on fluorescent intensity of the new chelate was studied. The results showed that Eu(TTA) 2(PMTBBP)Phen had more excellent PL properties and better film formation than that of Eu(TTA) 3Phen. [WT5HZ]
文摘Crohn’s disease is a chronic inflammatory disease process involving different sites in the gastrointestinal tract. Occasionally, so-called metastatic disease occurs in extra-intestinal sites. Granulomatous inflammation may be detected in endoscopic biopsies or resected tissues. Genetic, epigenetic and environmental factors appear to play a role. Multiple susceptibility genes have been described in both familial and non-familial forms while the disease is phenotypically heterogeneous with a female predominance. The disorder occurs over a broad age spectrum, from early childhood to late adulthood. More than 80% are diagnosed before age 40 years usually with terminal ileal and colonic involvement. Pediatric-onset disease is more severe and more extensive, usually with a higher chance of upper gastrointestinal tract disease, compared to adult-onset disease. Long-term studies have shown that the disorder may evolve with time into more complex disease with stricture formation and penetrating disease complications (i.e., fistula, abscess). Although prolonged remission may occur, discrete periods of symptomatic disease may re-appear over many decades suggesting recurrence or re-activation of this inflammatory process. Eventual development of a cure will likely depend on identification of an etiologic cause and a fundamental understanding of its pathogenesis. Until now, treatment has focused on removing risk factors, particularly cigarette smoking, and improving symptoms. In clinical trials, clinical remission is largely defined as improved numerical and endoscopic indices for “mucosal healing”. “Deep remission” is a conceptual, more “extended” goal that may or may not alter the long-term natural history of the disease in selected patients, albeit at a significant risk for treatment complications, including serious and unusual opportunistic infections.
基金Project supported by the National Natural Science Foundation of China (No. 20171036) the National Natural Science Foundation of Shaanxi Prov-ince (No. FF02328) and Education Committee of Shannxi Province (No. 01JK229).
文摘The title ternary complex Nd[(C5H8NS2)3(C12H8N2)] has been synthesized in absolute ethanol by the reaction of NdCl33.74H2O with ammonium pyrrolidinyldithiocarboxylate (APDC) and 1,10-phenanthroline (phenH2O) at air atmosphere without any cautions against moisture. The bonding characteristics of the complex were characterized by IR, showing that Nd3+ is bonded with sulfur atom in the APDC and coordinated with nitrogen atom in the phen. TG-DTG investigation indicates that the title complex was decomposed into Nd2S3 and deposited carbon in one step where Nd2S3 predominated in the final products. The enthalpy change of formation of the reaction on the title com-plex in liquid-phase has been determined by a microcalorimeter. Thermodynamic parameters (the activation en-thalpy, the activation entropy and the activation free energy) and kinetics parameters (the rate constant, the apparent activation energy, the pre-exponential constant and the reaction order) of the title reaction have been calculated. The enthalpy change of the solid-phase reaction has been obtained by a thermochemistry cycle.
基金the Science Foundation for Young Teachers of NENU(No.20070314)
文摘A supramolecular framework, 1.5Zn（phen）3·L·3NO3 （C63H48Zn1.5N16O9S）, has been synthesized. The ligand L was synthesized by the condensation of p-aminoacetophenone with thiosemicarbazide. The crystal belongs to the monoclinic system, space group C2/c, with a = 31.005（2）, b = 15.114（2）, c = 24.887（3） A, β = 94.260（2）° Z = 8, V = 11630（2）A^3 Dc = 1.489 g/cm^3, Mr = 1303.29,λ（MoKa） = 0.71069 A,μ= 0.735 mm^-1, F（000） = 5368, Rint = 0.0699, R= 0.0505 and wR= 0.0707. Two independent Zn atoms are both coordinated by six N atoms from three phen ligands. π-π and C-H…π interactions among the L ligands and Zn（phen）3 cations, π-π and C-H...π interactions among the Zn（phen）3 cations and N-H...O hydrogen bonds among the L ligands and nitrate anions connect the whole structure into a 3-D supramolecular framework.
基金supported by the National Natural Science Foundation of China (21073120, 20976104 and 21006063)the Special Funds for the Major State Basic Research Project of China (2007CB209705)the Science and Technology Commission of the Shanghai Municipality (09dz1203603,10dz1202702)
文摘A novel Co(phen)2/C catalyst was prepared by coating cobalt(II) phenanthroline (phen) chelate on BP2000 carbon black and then heat treating in an inert atmosphere. The obtained Co(phen)2/C product with 1.0 wt% cobalt loading exhibits similar morphology and porosity characteristics to those of the bare BP2000. X-ray diffraction measurements demonstrate a face-centered cubic (fcc) α-Co phase embedded in the carbon support after pyrolysis. Charge/discharge tests of the lithium-oxygen cells using the prepared Co(phen)2/C catalyst show high discharge capacities of 4870 mAh g-1 (0.05 mA cm-2 ), 3353 mAh g-1 (0.1 mA cm-2 ) and 3220 mAh g 1 (0.15 mA cm-2 ), respectively. The Co(phen) 2 /C cathode exhibits reasonable reversibility with capacity retention of 1401 mAh g-1 ( 0.1 mA cm-2 ) after 10 cycles. The superior electrochemical performance of the prepared Co(phen)2/C catalyst and low cost of the phenanthroline chelating agent indicate that Co(phen)2/C is a promising cheap catalyst for lithium-air batteries.
文摘A new compound（ClO4）2（H2O）0.5（azpy）was synthesized.Its structure was determined by single X-ray diffraction.The crystal belongs to triclinic system,space group P1.The crystallographic data:a=11.813（2）,b=12.574（2）,c=14.580（3）*!,a=84.048（6）,β=77.878（15）,γ=67.902（12）°,V=1961.1（7）*!3,Z=2,F（000）=926,Mr=904.57,Dc=1.532Mg/m3,μ=0.542mm-1,R1=0.0770,and wR2=0.1373.In the ctystal Mn（Ⅱ）ion is coordinated with six nitrogen from three phen ligands to form a distorted octahedron geometry.
文摘The crystal structures of two potential tumor imaging agents and therapeutic agents -copper(Ⅱ) complexes with salicylidene-tyrosinato Schiff base and nitrogen-donor chelating Lewis base, [Cu(sal-tyr)(bipy)] 1 and [Cu(sal-tyr)(phen)]2CH3OH 2 are presented. Our work is helpful to get deep understanding of novel 64Cu tumor imaging agents and therapeutic agents.
基金Project supported by Shanxi (20072194 and 20072185) Provincial Youth Technology Research Foundationthe Foundation of Taiyuan Graduate Innovation (100115133 and 100115131)
文摘A novel β-diketone, 1-（3,4,5-trisbenzyloxy）benzoyl-5-benzoyl acetylacetone （TBAA）, and its corresponding binary Tb（Ⅲ） complex Tb（TBAA）3·2H2O and ternary complex Tb（TBAA）3Phen with 1,10-phenanthroline （Phen） were prepared. The ligand was characterized based on elemental analysis, FT-IR, and 1H NMR. The complexes were characterized with elemental analysis, FT-IR and thermogravimetry and derivative thermogravimetry （TG-DTG）. Photoluminescence measurements indicated that the energy absorbed by the organic ligand was efficiently transferred to the central Tb3＋ ions, and the complex showed intense and characteristic emissions due to the 5D4→7FJ transitions of the central Tb3＋ ions. Both complexes showed longer fluorescence lifetimes. After the introduction of the second ligand Phen group, the relative emission intensities and fluorescence lifetimes of the ternary complex Tb（TBAA）3Phen enhanced more obviously than that of the binary complex Tb（TBAA）3·2H2O. This indicated that the presence of the ligand TBAA and the second ligand Phen could sensitize fluorescence intensities of Tb（Ⅲ） ions, and the introduction of Phen group resulted in the enhancement of the fluorescence properties of the Tb（Ⅲ） ternary rare earth complex.
